Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05A PARATHYROID HORMONES AND ANALOGUES
H05AA Parathyroid hormones and analogues
H05AA02 Teriparatide
D06078 Teriparatide (USP/INN) <JP/US>
USP drug classification [BR:br08302]
Metabolic Bone Disease Agents
Calcium Regulating Hormones
Teriparatide
D06078 Teriparatide (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
243 Thyroid and parathyroid hormone preparations
2439 Others
D06078 Teriparatide (USP/INN); Teriparatide (genetical recombination) (JAN); Teriparatide (genetical recombination) [Teriparatide biosimilar 1] (JAN)
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and parathyroid hormone-related protein analog
DG00512 Teriparatide
D06078 Teriparatide
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG00512 Teriparatide
D06078 Teriparatide
Drug classes [BR:br08332]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D06078 Teriparatide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Parathyroid hormone
PTH1R
D06078 Teriparatide (USP/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D06078
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D06078
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and parathyroid hormone-related protein analog
DG00512 Teriparatide
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG00512 Teriparatide